 The rapid surge from IRMs COVID lows drove investors into a state of complacency. But, we believe astute investors who saw the mayhem coming had already sold out. Notably, IRM fell nearly 25 from its September highs within three weeks, reminding investors about the perils of buying into overvalued stocks. 